Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases) - MarketsandMarkets

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases) - MarketsandMarkets
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)
Published Oct 26, 2012
130 pages — Published Oct 26, 2012
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:



This research report titled 'Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017)' provides details about various autologous cell based treatments and their application areas. Every health regulatory bodies will be expecting companies and universities to develop therapy treatments, which are Safer, Affordable, Robust, Rapid, Easy to use, Effective and Deliverable to the end user. Autologous stem cell transplantation for particular application areas is safe experiencing robust growth and has minimal steps of procedure to follow and is rapid in deriving the results. The sources for autologous stem cell therapy are Mesenchymal stem cells, Hematopoietic stem cells, Chondrocytes and so on. Currently, the cost of the treatments is not affordable however, by the intrusion of government bodies, this mode of treatment will certainly experience an immense market growth.

The report gives a detailed analysis about state of the art of both autologous stem cell and non-stem cell treatments. It includes the current advances and applications of the technology and trends in terms of market size and growth of autologous cellular therapies in medical treatments globally. It also consists of funding details of the innovative therapy and recent activities in terms of mergers & acquisitions of the company and revenue forecast. It includes latest autologous cultured cell treatment details and products which are available for licensing and approvals from various regulatory bodies. Using drivers, restraints and challenges, the market revenue is forecasted for a period of five years, i.e. 2012-2017. Opportunity strategy evaluation has been included which gives information on potential application areas for investments.

Autologous Stem Cell Therapy technology (a form of regenerative cell therapy) is changing the medicinal treatments by introducing various new therapies. Its scope is vast and promising for the future despite challenges.

  
Source:
Document ID
PH 1300
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS:

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT SCOPE
1.3 RESEARCH METHODOLOGY
1.4 KEY DATA SOURCES

2 EXECUTIVE SUMMARY

3 AUTOLOGOUS STEM CELL & NON STEM SELL THERAPY -TECHNOLOGY LANDSCAPE ANALYSIS
3.1 AUTOLOGOUS CELL THERAPY TECHNOLOGY
3.1.1 AUTOLOGOUS CELL TECHNOLOGY OVERVIEW
3.1.2 AUTOLOGOUS CELL TECHNOLOGY PROCESS
3.1.3 APPLICATION AREAS
3.1.3.1 NEURODEGENERATIVE DISEASES
3.1.3.2 CARDIOVASCULAR DISEASES
3.1.3.3 CANCER AND AUTOIMMUNE DISEASES
3.1.3.4 SKIN TRANSPLANTATION
3.1.3.5 INFECTIOUS DIESEASE
3.2 TECHNOLOGY TREND ANALYSIS
3.3 VALUE CHAIN ANALYSIS

4 AUTOLOGOUS STEM CELL & NON STEM SELL THERAPY TECHNOLOGY INVESTMENT POTENTIAL
4.1 INVESTMENT CLIMATE ASSESSMENT
4.1.1 INVESTOR NETWORKS
4.1.1.1 PUBLIC FUNDING BODIES
4.1.1.2 FUNDING/GRANTS FROM NGO ORGANIZATIONS
4.1.1.3 PRIVATE INVESTORS AND VENTURE CAPITAL FIRMS
4.1.1.4 INSIGHTS ON CURRENT AND FUTURE TECH-INVESTMENT TRENDS
4.1.1.5 INVESTOR INCLINATION AND PATTERNS
4.2 INVESTMENT OPPURTUNITIES
4.2.1 LICENSING AND ACQUISITION
4.2.2 ANALYSIS OF POTENTIAL APPLICATION AREAS FOR TECHNOLOGY INVESTMENT

5 AUTOLOGOUS STEM CELL & NON STEM SELL THERAPY MARKET LANDSCAPE ANALYSIS
5.1 AUTOLOGOUS VS ALLOGENIC - MARKET LANDSCAPE
5.2 GLOBAL MARKET FORECAST
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.2 RESTRAINTS
5.3.3 CHALLENGES
5.3.4 DEMAND SIDE ANALYSIS

6 AUTOLOGOUS STEM CELL & NON STEM SELL THERAPY - TECHNOLOGY ADOPTION POTENTIAL AND DEVELOPMENT BY GEOGRAPHY
6.1 INTRODUCTION
6.2 US, CANADA, LATIN AMERICA
6.3 UK, GERMANY, FRANCE
6.4 AUSTRALIA, KOREA, JAPAN, ROW
6.5 REGIONS WITH HIGH TECHNOLOGY ADOPTION

7 COMPETITIVE LANDSCAPE
7.1 MERGERS AND ACQUISITIONS
7.2 PARTNERSHIPS AND COLLABORATIONS
7.3 NEW PRODUCT DEVELOPMENT INITIATIVES (THOSE IN PIPELINE)

8 PATENT ANALYSIS

9 TECHNOLOGY ANALYSIS AND ROAD MAPPING
9.1 INTRODUCTION
9.2 CLINICAL TRIALS DETAILS - MEDICAL CENTERS AND UNIVERSITIES
9.3 DATA PERTAINING TO AUTOLOGOUS CELL THERAPY CLINICAL TRIALS

10 ANALYST INSIGHTS AND RECOMMENDATIONS

11 COMPANY PROFILES
11.1 ANTRIA (CRO) (U.S.)
11.2 BIOHEART (U.S.)
11.3 BRAINSTORM CELL THERAPEUTICS (U.S.)
11.4 CYTORI (U.S.)
11.5 DENDREON CORPORATION (U.S.)
11.6 FIBROCELL (U.S.)
11.7 GENESIS BIOPHARMA (U.S.)
11.8 GEORGIA HEALTH SCIENCES UNIVERSITY (U.S.)
11.9 NEOSTEM (U.S.)
11.10 OPEXA THERAPEUTICS (U.S.)
11.11 ORGENESIS (U.S.)
11.12 REGENEXX (U.S.)
11.13 REGENEUS (AUSTRALIA)
11.14 TENGION (U.S.)
11.15 TIGENIX (BELGIUM)
11.16 VIRXSYS (U.S.)

12 APPENDIX

13 GLOSSARY


LIST OF TABLES

TABLE 1 FUNDING DETAILS IN EUROPE
TABLE 2 LICENSING & ACQUISITION
TABLE 3 DATA PERTAINING TO DISEASES - DISEASE INCIDENCE & TREATMENT COSTS
TABLE 4 DRIVERS
TABLE 5 RESTRAINTS
TABLE 6 U.S. FDA GUIDANCE DOCUMENTS
TABLE 7 MERGERS & ACQUISITIONS
TABLE 8 PARTNERSHIPS & COLLABORATIONS
TABLE 9 NEW PRODUCT DEVELOPMENT INIT

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)" Oct 26, 2012. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Autologous-Stem-Cell-and-Non-Stem-Cell-Based-Therapies-Market-2012-2017-Neurodegenerative-Cardiovascular-Cancer-Autoimmune-Skin-and-Infectious-Diseases-2144-355>
  
APA:
MarketsandMarkets. (2012). Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases) Oct 26, 2012. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Autologous-Stem-Cell-and-Non-Stem-Cell-Based-Therapies-Market-2012-2017-Neurodegenerative-Cardiovascular-Cancer-Autoimmune-Skin-and-Infectious-Diseases-2144-355>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.